Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods.
behavioral science
cancer care
cancer education
cancer management
Journal
Cancer reports (Hoboken, N.J.)
ISSN: 2573-8348
Titre abrégé: Cancer Rep (Hoboken)
Pays: United States
ID NLM: 101747728
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
revised:
18
07
2021
received:
02
05
2021
accepted:
14
08
2021
pubmed:
29
9
2021
medline:
9
8
2022
entrez:
28
9
2021
Statut:
ppublish
Résumé
Multidisciplinary care is pivotal in cancer centres and the interaction of all cancer disease specialists in decision making processes is state-of-the-art. To describe differences of MDTMs by tumour type. Twelve multidisciplinary team meetings (MDTMs) with participation of different cancer disease specialists at a tertiary hospital were assessed by an exploratory sequential mixed method approach with interviews, observations and a survey to address the following five topics: organisational structure and supporting technology; leadership; teamwork; decision-making, perceived value and motivation. Thirteen persons with different tumour specialities and levels of seniority were interviewed. The 12 MDTMs were observed twice by uninvolved persons and evaluated by the participating physicians with a survey. There were no systematic differences between MDTMs for different tumour types with the exception of the non-disease specific type MDTM, which was the only one for which the organisational structure was not driven by an electronic tool. However, several factors could be identified that generally influenced the functioning of the MDTMs. In particular, the quality of decision-making was highly dependent on the availability of case-based information and the presence of relevant cancer disease specialists. Leadership and teamwork were rated as important and were comparable across the MDTM. Team participants' motivation and perceived value of MDTMs was high across all meetings. MDTM at a single institution did not demonstrate disease specific characteristics. An effective MDTM, irrespective of the tumour type, can be successfully structured by technical means and a chairperson coordinating the interaction of cancer disease specialists to improve the decision-making process.
Sections du résumé
BACKGROUND
Multidisciplinary care is pivotal in cancer centres and the interaction of all cancer disease specialists in decision making processes is state-of-the-art.
AIM
To describe differences of MDTMs by tumour type.
METHODS
Twelve multidisciplinary team meetings (MDTMs) with participation of different cancer disease specialists at a tertiary hospital were assessed by an exploratory sequential mixed method approach with interviews, observations and a survey to address the following five topics: organisational structure and supporting technology; leadership; teamwork; decision-making, perceived value and motivation. Thirteen persons with different tumour specialities and levels of seniority were interviewed. The 12 MDTMs were observed twice by uninvolved persons and evaluated by the participating physicians with a survey.
RESULTS
There were no systematic differences between MDTMs for different tumour types with the exception of the non-disease specific type MDTM, which was the only one for which the organisational structure was not driven by an electronic tool. However, several factors could be identified that generally influenced the functioning of the MDTMs. In particular, the quality of decision-making was highly dependent on the availability of case-based information and the presence of relevant cancer disease specialists. Leadership and teamwork were rated as important and were comparable across the MDTM. Team participants' motivation and perceived value of MDTMs was high across all meetings.
CONCLUSION
MDTM at a single institution did not demonstrate disease specific characteristics. An effective MDTM, irrespective of the tumour type, can be successfully structured by technical means and a chairperson coordinating the interaction of cancer disease specialists to improve the decision-making process.
Identifiants
pubmed: 34582132
doi: 10.1002/cnr2.1541
pmc: PMC9351662
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1541Subventions
Organisme : Department of Health
Pays : United Kingdom
Informations de copyright
© 2021 The Authors. Cancer Reports published by Wiley Periodicals LLC.
Références
J Pers Soc Psychol. 1998 Jul;75(1):93-108
pubmed: 9686452
Am Psychol. 2018 May-Jun;73(4):433-450
pubmed: 29792459
BMC Health Serv Res. 2018 Apr 5;18(1):249
pubmed: 29622020
Health Policy. 2010 Mar;94(3):183-95
pubmed: 19857910
Ann Oncol. 2014 Jan;25(1):9-15
pubmed: 24335854
Med Care. 2015 Apr;53(4):e16-30
pubmed: 24189550
JCO Clin Cancer Inform. 2019 Feb;3:1-9
pubmed: 30730766
World J Urol. 2018 Jul;36(7):1031-1038
pubmed: 29502300
J Glob Oncol. 2015 Oct 28;1(2):57-64
pubmed: 28804774
Curr Oncol. 2019 Jun;26(3):e385-e397
pubmed: 31285683
Br J Cancer. 2003 Jul 7;89(1):15-22
pubmed: 12838294
Cancer Rep (Hoboken). 2022 Aug;5(8):e1541
pubmed: 34582132
Anesth Analg. 2012 Nov;115(5):1099-108
pubmed: 23011565
Qual Health Care. 2001 Jun;10(2):65-6
pubmed: 11389310
Ann Surg Oncol. 2011 Dec;18(13):3535-43
pubmed: 21594706
Eur J Cancer Care (Engl). 2014 Sep;23(5):616-23
pubmed: 24372588
Patient Educ Couns. 2021 Apr;104(4):792-799
pubmed: 33051128
BMJ Open. 2019 Apr 8;9(4):e024621
pubmed: 30962228
Front Psychol. 2019 Jun 28;10:1478
pubmed: 31316435
Lancet. 2010 Dec 4;376(9756):1923-58
pubmed: 21112623
J Multidiscip Healthc. 2021 Jun 01;14:1275-1284
pubmed: 34103928
Ann Surg Oncol. 2012 Jun;19(6):1759-65
pubmed: 22207050
Cancer Nurs. 2021 Nov-Dec 01;44(6):E476-E492
pubmed: 33913442
Ann Surg Oncol. 2011 Aug;18(8):2116-25
pubmed: 21442345
BMJ. 2000 Jan 8;320(7227):114-6
pubmed: 10625273
Int J Breast Cancer. 2011;2011:831605
pubmed: 22295234
Medicine (Baltimore). 2016 Jun;95(24):e3885
pubmed: 27310981
World J Surg. 2011 Sep;35(9):1970-6
pubmed: 21604049
Ann Surg Oncol. 2013 Mar;20(3):715-22
pubmed: 23064794
Ann Oncol. 2006 Mar;17(3):457-60
pubmed: 16322114
J Telemed Telecare. 2005;11 Suppl 2:S29-34
pubmed: 16447355
Am Soc Clin Oncol Educ Book. 2014;:e461-6
pubmed: 24857140
Qual Saf Health Care. 2004 Oct;13 Suppl 1:i96-104
pubmed: 15465963
Surg Oncol. 2011 Sep;20(3):163-8
pubmed: 20719499
Health Serv Res. 2013 Dec;48(6 Pt 2):2134-56
pubmed: 24279835
J Natl Cancer Inst Monogr. 2010;2010(40):72-80
pubmed: 20386055
Hum Resour Health. 2020 Jan 8;18(1):2
pubmed: 31915007
Eur J Cancer. 2006 Oct;42(15):2459-62
pubmed: 16934974
Ann Oncol. 2012 May;23(5):1293-1300
pubmed: 22015450